Accounts filed on 31-12-2014


2013-11-072014-12-3108766142falsetruehttp://www.companieshouse.gov.uk/cd:Director12013-11-072014-12-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12013-11-072014-12-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12014-12-31http://www.companieshouse.gov.uk/2013-11-072014-12-31http://www.companieshouse.gov.uk/2014-12-31http://www.companieshouse.gov.uk/2013-11-06iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 08766142

Chemo Lifesciences Limited

ABBREVIATED ACCOUNTS
FOR THE 420 DAY PERIOD ENDED 31/12/2014



Chemo Lifesciences Limited

ABBREVIATED ACCOUNTS
FOR THE 420 DAY PERIOD ENDED 31/12/2014
INDEX TO THE ACCOUNTS
Abbreviated Balance Sheet2
Notes to the Abbreviated Accounts3
The company's registered number is 08766142


Chemo Lifesciences Limited

Registered Number: 08766142
BALANCE SHEET AT 31/12/2014
2014
Notes£
CURRENT ASSETS
Debtors (amounts falling due within one year)230,446
Cash at bank and in hand2,633,309
2,663,755
CREDITORS: Amounts falling due within one year2,783,328
NET CURRENT LIABILITIES(119,573)
TOTAL ASSETS LESS CURRENT LIABILITIES(119,573)
CAPITAL AND RESERVES
Called up share capital31
Profit and loss account(119,574)
SHAREHOLDERS' FUNDS(119,573)
For the year ending 31/12/2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 03/08/2015 and signed on their behalf by
Geoffrey Hugh Melamet
Director


Chemo Lifesciences Limited

NOTES TO THE ACCOUNTS
FOR THE 420 DAY PERIOD ENDED 31/12/2014
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).
1b. Cash Flow Statement
The Company is exempt from including a statement of cash flows in its accounts in accordance with Financial Reporting Standard for Smaller Entities (effective April 2008).
1c. Foreign Currency
Transactions in foreign currency are translated at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the exchange rate ruling at that date. Foreign exchange gains and losses are recognised in the income statement. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.
1d. Turnover
Turnover represents the invoiced value of goods and services supplied by the company, net of value added tax and trade discounts.
2. DEBTORS 2014
£
Amounts falling due within one year:
VAT11,779
Other debtors18,667
30,446


Chemo Lifesciences Limited

3. SHARE CAPITAL 2014
£
Allotted, issued and fully paid:
1 Class 1 shares of £1 each1
1